Erlonat Tablets IP

• Application
• Other, Oncology, Chemotherapy

• Dosage Form
• Tablet

• Enzymatic Activity
• Blocks EGFR tyrosine kinase

• Enzyme Types
• Other, Tyrosine kinase inhibitor (TKI)

• Feature
• Other, Film-coated, prescription only

• Fermentation Smell
• Other, Odorless

• Indication
• Non-small cell lung cancer, Pancreatic cancer

• Ingredients
• Other , Erlotinib Hydrochloride, Excipients

• Physical Color/Texture
• Other , White to off-white, round tablet

• Salt Composition
• Erlotinib Hydrochloride

• Shelf Life
• 24 months from date of manufacture

• Storage Instructions
• Store below 30C, protected from moisture and light

• Application
• Other, Anticancer therapy

• Dosage Form
• Tablet

• Enzyme Types
• Other

• Feature
• Other, Prescription Only, Oral Use

• Fermentation Smell
• Other, Odorless

• Ingredients
• Other , Erlotinib Hydrochloride, Excipients

• Origin
• India

• Salt Composition
• Erlotinib Hydrochloride 150 mg

• Shelf Life
• 24 months

• Storage Instructions
• Store below 30C, in a dry place and protect from light

• Application
• Other, Oncology, targeted cancer therapy

• Dosage Form
• Tablets

• Feature
• Other, Orally administered, specific for EGFR mutations

• Ingredients
• Other , Erlotinib Hydrochloride, excipients

• Origin
• India

• Salt Composition
• Erlotinib Hydrochloride

• Shelf Life
• 24 months

• Storage Instructions
• Store below 30C, protect from light and moisture